Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Biogen is ramping up in RTP with a fresh $2 billion investment. © 2025 American City Business Journals. All rights reserved.

Coriolis Pharma is investing $10 million to establish a research lab in Morrisville, North Carolina, creating 50 new jobs and ...

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

In a report released yesterday, Geoff Meacham from Citi maintained a Hold rating on Biogen, with a price target of $125.00. The company’s shares closed yesterday at $122.68. Take advantage of TipRanks ...

Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...

Coriolis Pharma, a pharmaceutical services company based in Germany, is investing $10 million to build a laboratory at Spark ...

Modernization of “manufacturing technologies and controls through further advanced automation and artificial intelligence” ...

Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The ...

Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.

One of North Carolina’s largest life sciences companies, Biogen Inc. (Nasdaq BIIB), is celebrating its 30th anniversary in ...

RESEARCH TRIANGLE PARK, N.C. (WTVD) -- Global biotechnology firm Biogen announced a major investment in its Research Triangle Park hub. The company said it will spend $2 billion to expand its North ...